Swedish Orphan Biovitrum AB - Company Profile

Powered by

All the sales intelligence you need on Swedish Orphan Biovitrum AB in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Swedish Orphan Biovitrum AB fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Swedish Orphan Biovitrum AB.

Back to companies

Swedish Orphan Biovitrum AB: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on Swedish Orphan Biovitrum AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Swedish Orphan Biovitrum AB's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

David Meek

Chairman Executive Board Since: 2024 Age: 63

Mr. David Meek has been the Chairman of the company since 2024. He also serves as the Chief Executive Officer at Genetix and Director at Cullinan Therapeutics, uniQure. Prior to this, he served as the Chief Executive Officer and Board Director of Mirati Therapeutics, FerGene Inc and Ipsen SA.

Read Hide full bio of David Meek

Guido Oelkers

Chief Executive Officer Senior Management Since: 2017 Age: 61

Mr. Guido Oelkers has been the Chief Executive Officer of the company since 2017. Prior to this, he served as the President and Chief Executive Officer of Gambro. Previously, he served as the Executive Vice President of Commercial Operations at Nycomed. He served as the Chief Executive Officer at Invida. He served as the Global Head of Healthcare at DKSH. He also served as the Director at Meda and Sartorius AG.

Read Hide full bio of Guido Oelkers

Henrik Stenqvist

Chief Financial Officer Senior Management Since: 2018 Age: 59

Mr Henrik Stenqvist has been the Chief Financial Officer of the company since 2018. Prior to this, he served as the Chief Financial Officer at Recipharm and Meda Group. Previously, he served as the Finance Director at Astra Export & Trading. He also served as the Director at MedCap AB, Midsona AB, and Calliditas Therapeutics AB.

Read Hide full bio of Henrik Stenqvist

Lydia Abad-Franch

Chief Medical Officer; Head - Medical Affairs; Head - Research & Development Senior Management Since: 2020 Age: 55

Ms Lydia Abad-Franch has been the Chief Medical Officer and Head of Research & Development of the company since 2023. Prior to this, she served as the Senior Medical Director at Global Medical Affairs at Shire/Takeda. Previously, she served as the Medical Director of Global Medical Affairs at Shire/Baxalta. He served as the Associate Medical Director at Baxter EMEA.

Read Hide full bio of Lydia Abad-Franch

Norbert Oppitz

Head - International Senior Management Since: 2017 Age: 59
Gain a 360-degree view of Swedish Orphan Biovitrum AB and make more informed decisions for your business Gain a 360-degree view of Swedish Orphan Biovitrum AB and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer